P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
ABIO | N/A | N/A | N/A | +32.78% |
ABIO Peer | N/A | N/A | N/A | +85.18% |
Pharmaceuticals: Major Industry | 24.7 | 16.9 | 0.3 | +50.93% |
Health Technology Sector | 32.9 | 21.4 | 0.5 | +26.68% |
S&P 500 Market | 32.3 | 27.3 | 1.1 | +98.98% |
Q3 2021 | Q4 2021 | Q2 2021 | Q | |
---|---|---|---|---|
Mean Estimate | -$2.30 | -$2.24 | N/A | N/A |
Previous Mean | -$2.30 | -$2.24 | N/A | N/A |
Standard Deviation | N/A | N/A | N/A | N/A |
Low Estimate | -$2.30 | -$2.24 | N/A | N/A |
High Estimate | -$2.30 | -$2.24 | N/A | N/A |